Vertex pharmaceuticals qtrly product revenues up 62%

Vertex reports second-quarter 2020 financial results.qtrly product revenues of $1.52 billion, a 62% increase compared to q2 2019.company raises revenue guidance; now expects 2020 cf revenues of $5.7 billion to $5.9 billion.qtrly gaap net income per share - diluted $ 3.18.qtrly non-gaap net income per share - diluted $ 2.61.q2 earnings per share view $2.07, revenue view $1.39 billion -- refinitiv ibes data.fy2020 revenue view $5.73 billion -- refinitiv ibes data.
VRTX Ratings Summary
VRTX Quant Ranking